Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Authors
Keywords
Cerebrospinal fluid, Alzheimers disease, Cognitive impairment, Cytokines, Dementia, Chemokines, Biomarkers, Vascular dementia
Journal
PLoS One
Volume 12, Issue 5, Pages e0176760
Publisher
Public Library of Science (PLoS)
Online
2017-05-03
DOI
10.1371/journal.pone.0176760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias
- (2016) Aiqing Chen et al. NEUROBIOLOGY OF AGING
- Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer’s Disease
- (2015) Istvan Horvath et al. ACS Chemical Neuroscience
- The Role of Neuroinflammation in Dementias
- (2015) Giuseppe Pasqualetti et al. Current Neurology and Neuroscience Reports
- Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer’s Disease
- (2014) Prem Prakash Gupta et al. American Journal of Alzheimers Disease and Other Dementias
- IL-12-and IL-23 in health and disease
- (2014) Andrew L. Croxford et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese
- (2014) Ying Liu et al. JOURNAL OF NEUROIMMUNOLOGY
- Association of IL-12A and IL-12B polymorphisms with Alzheimer's disease susceptibility in a Han Chinese population
- (2014) Xi-Chen Zhu et al. JOURNAL OF NEUROIMMUNOLOGY
- Systemic immune system alterations in early stages of Alzheimer's disease
- (2013) Rongzhen Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Sustained Interleukin-1 Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
- (2013) S. Ghosh et al. JOURNAL OF NEUROSCIENCE
- Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment
- (2013) Li Huang et al. NEUROSCIENCE LETTERS
- Acetylcholinesterase Inhibitors Reduce Neuroinflammation and -Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model
- (2013) Alexander Kalb et al. PLoS One
- Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease
- (2012) Mohamad A. Alsadany et al. American Journal of Alzheimers Disease and Other Dementias
- The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
- (2012) A. Koyama et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
- (2012) Johannes vom Berg et al. NATURE MEDICINE
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
- (2012) Karin Westin et al. PLoS One
- Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
- (2011) Sam-Moon Kim et al. BMC Neurology
- Systemic Inflammation Is Associated with MCI and Its Subtypes: The Sydney Memory and Aging Study
- (2011) Julian N. Trollor et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease
- (2011) Sigbritt Rasmuson et al. INTERNATIONAL PSYCHOGERIATRICS
- Role of Interleukin 6 and Alpha-Globulins in Differentiating Alzheimer and Vascular Dementias
- (2011) Azza A. Helmy et al. Neurodegenerative Diseases
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
- (2009) Paramita Chakrabarty et al. FASEB JOURNAL
- Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
- (2008) Gabor G. Kovacs et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
- (2008) D. Galimberti et al. JOURNAL OF NEUROLOGY
- Protective effects of NSAIDs on the development of Alzheimer disease
- (2008) Steven C. Vlad et al. NEUROLOGY
- Systemic immune aberrations in Alzheimer's disease patients
- (2007) Konstantinos Bonotis et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now